Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Frailty is a common clinical syndrome in older adults that increases the risk for poor health outcomes including falls, disability, hospitalization, and mortality. Previous research showed increased protein needs and reduced anabolic response to meals in older adults, indicating the need for proteins with a high anabolic capacity to prevent and attenuate physical and cognitive health decline throughout the frailty cycle. Recently, more people have chosen to eliminate animal (i.e., beef) products from their diets which is concerning because of beef's anabolic properties due to high essential amino acid (EAA) levels and many other positive health effects. The Researchers' recently developed stable isotope amino acid pulse method enables measurement of the true intracellular anabolic response to a meal and bioavailability of food-derived amino acids. The research objective is to examine differences in the anabolic response and bioavailability of individual EAA and non-essential amino acids (NEAA) in beef as compared to plant protein in older adults with and without (pre-)frailty.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

NCT06628349

Protein Metabolism

RECRUITING NA

The Effect of Culinary Medicine to Enhance Protein Intake on Muscle Quality in Older Adults

NCT06157385

Sarcopenia

COMPLETED NA

The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

NCT07167277

Pre-frail Pre-Frail Older Adults Cognition +3 more

RECRUITING NA

The Impact of Beef on Muscle Fatigue in Older Adults

NCT05860088

Muscle Weakness Muscle; Fatigue, Heart Older Adults

RECRUITING NA

Optimizing Protein Intake in Older Americans With Mobility Limitations

NCT01275365

Mobility Limitation

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Beef protein is known for its anabolic properties due to its high EAA levels and digestibility (\~ 94% compared to 78% in beans and 86% in whole wheat). However, whether beef has the most optimal composition of individual EAA and non-essential amino acids (NEAA) for older adults with (pre)frailty remains unclear as well as the role of the individual branched-chain amino acids (BCAA) leucine, isoleucine and valine. Research is of scientific and clinical importance to understand whether (pre)frail older adults respond better to certain protein sources (i.e., beef protein) due to a more optimal profile/pattern of individual EAA and NEAA amino acids.

The study will take place at the research facility of the Center for Translational Research on Aging and Longevity (CTRAL), Texas A\&M University located in the Human Clinical Research Building ) affiliated with Texas A\&M University. The study involves 1 screening visit of approx. 3 hours, and 4 study days. Some study procedures (e.g., body composition, skeletal muscle function, questionnaires) may be skipped if completed within the past 3 months at CTRAL. All data will be recorded in Case Report Form and stored in the Texas A\&M REDCap System. Subjects will be asked to arrive in the fasted state on all study days. Fasting prior to screening is not required. On the screening day, body weight, height, and body composition by Dual-energy X-ray absorptiometry (DXA) will be measured. In addition, The Six-Minute Walk Test (6MWT) and skeletal muscle function tests will be assessed at the end of each screening visit. Each study visit will begin with vital signs. Before administration of the feeding or the tracer solution, baseline blood will be collected for measurement of the natural enrichment of metabolites. After the baseline sample is collected, feeding will begin and will be followed by tracers of several compounds that may be administered by IV pulse. Participants will receive bites and sips of nutrition every 20 minutes for 5 hours. Participants will consume, using a randomized cross-over design, using a bite feeding method of the following proteins: (1) beef, (2) tofu (soy as the most popular plant-based protein) or (3) water (placebo to correct the anabolic data obtained after intake of the proteins for baseline (postabsorptive) values).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Protein Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Frail older adults

based on the Fried index

Group Type EXPERIMENTAL

Beef

Intervention Type OTHER

Beef, ground, 93% lean meat / 7% fat, patty, cooked, broiled: 100g = 26.2 g protein

Tofu

Intervention Type OTHER

Fried tofu: 100g = 18.8 g protein

Placebo

Intervention Type OTHER

water (to correct the anabolic data obtained after intake of the proteins for baseline (postabsorptive) values

Pre-Frail Older Adults

based on the Fried index

Group Type EXPERIMENTAL

Beef

Intervention Type OTHER

Beef, ground, 93% lean meat / 7% fat, patty, cooked, broiled: 100g = 26.2 g protein

Tofu

Intervention Type OTHER

Fried tofu: 100g = 18.8 g protein

Placebo

Intervention Type OTHER

water (to correct the anabolic data obtained after intake of the proteins for baseline (postabsorptive) values

Non-Frail Older Adults

based on the Fried index

Group Type EXPERIMENTAL

Beef

Intervention Type OTHER

Beef, ground, 93% lean meat / 7% fat, patty, cooked, broiled: 100g = 26.2 g protein

Tofu

Intervention Type OTHER

Fried tofu: 100g = 18.8 g protein

Placebo

Intervention Type OTHER

water (to correct the anabolic data obtained after intake of the proteins for baseline (postabsorptive) values

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beef

Beef, ground, 93% lean meat / 7% fat, patty, cooked, broiled: 100g = 26.2 g protein

Intervention Type OTHER

Tofu

Fried tofu: 100g = 18.8 g protein

Intervention Type OTHER

Placebo

water (to correct the anabolic data obtained after intake of the proteins for baseline (postabsorptive) values

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 65-95 years old
* Ability to walk, sit down, and stand up (independently or with walking assistance device)
* No recent use (\< 4 weeks prior to start of the study) of dietary supplements and medication influencing protein and amino acid metabolism (e.g., antibiotics, oral corticosteroids)
* Willingness to lay supine in bed for up to 6 hours
* Willingness and ability to comply with the protocol

Exclusion Criteria

* Presence of malnutrition (BMI \< 17 kg/m2), 2). BMI \>35 kg/m2 to avoid weight-related metabolic disturbances,
* Established diagnosis and active treatment of chronic disease: Insulin-dependent diabetes mellitus, active malignancy, heart disease, kidney disease, liver disease, HIV/AIDS, Asthma (moderate to severe), Hep (A, B, or C)
* History of untreated metabolic disease including hepatic or renal disorder
* Presence of fever within the last 3 days
* Cirrhosis of liver
* Diagnosis of dementia, neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease, Huntington's chorea, frontotemporal dementia).
* (Possible) pregnancy
* Presence of acute illness or metabolically unstable chronic illness
* Active dependence on alcohol or drugs
* Newly prescribed long-term oral corticosteroids
* Planned elective surgery requiring 2 or more days of hospitalization during the entire study
* Failure to give informed consent or Investigator's uncertainty about the willingness or ability of the subject
* Already enrolled in another clinical trial
* Any condition according to the PI or nurse that was found during the screening visit, that would interfere with the study or safety of the patient
* Known allergy to any of the components of the feeding (soy, beef)
* Established daily diet of vegetarian/vegan composition

Minimum Eligible Age

65 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes